Sientra Implants Study

As a leader in the field of plastic surgery, board-certified plastic surgeon Dr. Jennifer Harrington was appointed as the medical director for the longest clinical study to date on the effects of high-strength silicone gel (“gummy bear”) breast implants. Her leadership in the area of women’s health and safety has benefited not only her own patients in the Twin Cities area, but also women nationwide.

As a firm believer in delivering the highest quality cosmetic services, Dr. Harrington has used Sientra products since the beginning of her practice. Dr. Harrington’s patients who took part in the study between 2002 and 2007 reported their happiness with both the product and their results.*

The results of the study, published in the April 2018 issue of the ASPS Plastic and Reconstructive Surgery journal, show a lower rate of capsular contracture in textured breast implants compared to smooth, and zero incidence of breast implant–associated anaplastic large cell lymphoma in study participants. In other words, Sientra’s gummy bear breast implants indicate a comprehensive degree of both safety and effectiveness.* 

The Online Annual Sientra Implant Study (O.A.S.I.S.) was designed to assess long-term outcomes of silicone gel breast implants. The study collected extensive health data from participants who had either round or teardrop-shaped gummy bear breast implants filled with a high-strength cohesive gel.

Sientra gummy bear implants offer women the advantage of maintaining their shape regardless of potential ruptures or other complications. These implants also offer a natural feel that mimics the texture of breast tissue. Sientra offers gummy bear implants in either round or anatomical form so women can select the implant that will work best with their natural anatomy.*

The study included both breast augmentation and breast reconstruction patients who chose high-strength silicone gel implants. Dr. Harrington reimbursed her patients who completed surveys to assist in the collection of thorough and accurate data. Her patients are also required to revisit her yearly for up to 10 years to ensure that they continue to enjoy their results as well as optimal breast health.

We now offer proactive breast implant screenings using Butterfly IQ+, a non-invasive ultrasound imaging system that promotes peace of mind and helps to assess implant integrity.

This enhanced diagnostic tool for proactive surveillance of breast implant outcomes gives our breast augmentation patients an easy way to follow the current FDA recommendations for ongoing screening.

We offer diagnostics for existing and new patients. Contact us to learn more during your consultation.